Convergence: lactosylceramide-centric signaling pathways induce inflammation, oxidative stress, and other phenotypic outcomes

S Chatterjee, A Balram, W Li - International journal of molecular sciences, 2021 - mdpi.com
Lactosylceramide (LacCer), also known as CD17/CDw17, is a member of a large family of
small molecular weight compounds known as glycosphingolipids. It plays a pivotal role in …

Potential therapeutic targets for atherosclerosis in sphingolipid metabolism

Z Yu, Q Peng, Y Huang - Clinical Science, 2019 - portlandpress.com
Sphingolipids, such as sphingomyelins, ceramides, glycosphingolipids, and sphingosine-1-
phosphates (S1P) are a large group of structurally and functionally diverse molecules. Some …

Plasma sphingolipids and risk of cardiovascular diseases: a large-scale lipidomic analysis

JYH Seah, WS Chew, F Torta, CM Khoo, MR Wenk… - Metabolomics, 2020 - Springer
Introduction Sphingolipids are a diverse class of lipids with various roles in cell functions
and subclasses such as ceramides have been associated with cardiovascular diseases …

Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease

GC Baccam, J Xie, X Jin, H Park, B Wang, H Husson… - Scientific reports, 2022 - nature.com
A significant population of patients with chronic kidney disease (CKD) develops cardiac
hypertrophy, which can lead to heart failure and sudden cardiac death. Soluble klotho (sKL) …

Crossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral …

P Sfyri, A Matsakas - Journal of biomedical science, 2017 - Springer
Atherosclerosis is a chronic inflammatory process that, in the presence of hyperlipidaemia,
promotes the formation of atheromatous plaques in large vessels of the cardiovascular …

Sphingolipid profiling: a promising tool for stratifying the metabolic syndrome-associated risk

L Berkowitz, F Cabrera-Reyes, C Salazar… - Frontiers in …, 2022 - frontiersin.org
Metabolic syndrome (MetS) is a multicomponent risk condition that reflects the clustering of
individual cardiometabolic risk factors related to abdominal obesity and insulin resistance …

Bioactive lipid signaling in cardiovascular disease, development, and regeneration

AH Wasserman, M Venkatesan, A Aguirre - Cells, 2020 - mdpi.com
Cardiovascular disease (CVD) remains a leading cause of death globally. Understanding
and characterizing the biochemical context of the cardiovascular system in health and …

Lipid profile and left ventricular geometry pattern in obese children

B Bjelakovic, C Stefanutti, V Vukovic, N Kavaric… - Lipids in Health and …, 2020 - Springer
Background Left ventricular hypertrophy (LVH) is an important risk factor for cardiovascular
and all-cause mortality. Previous studies reported conflicting results concerning the …

Central Role of β-1, 4-GalT-V in Cancer Signaling, Inflammation, and Other Disease-Centric Pathways

S Chatterjee, R Yuan, S Thapa, R Talwar - International journal of …, 2023 - mdpi.com
UDP-Galactose: Glucosylceramide, β-1, 4-Galactose transferase-V (β-1, 4-GalT-V), is a
member of a large glycosyltransferase family, primarily involved in the transfer of sugar …

Colocalization of receptors for Shiga toxins with lipid rafts in primary human renal glomerular endothelial cells and influence of D-PDMP on synthesis and distribution …

N Legros, G Pohlentz, J Runde, S Dusny… - …, 2017 - academic.oup.com
Damage of human renal glomerular endothelial cells (HRGECs) of the kidney represents the
linchpin in the pathogenesis of the hemolytic uremic syndrome caused by Shiga toxins of …